China · Delayed Price · Currency is CNY Cabio Biotech (Wuhan) Statistics
Total Valuation
SHA:688089 has a market cap or net worth of CNY 1.39 billion. The enterprise value is 1.22 billion.
| Market Cap | 1.39B |
| Enterprise Value | 1.22B |
Important Dates
The last earnings date was Saturday, August 22, 2026.
| Earnings Date | Aug 22, 2026 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
SHA:688089 has 164.51 million shares outstanding. The number of shares has decreased by -0.44% in one year.
| Current Share Class | 164.51M |
| Shares Outstanding | 164.51M |
| Shares Change (YoY) | -0.44% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | 6.68% |
| Float | 84.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.43 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 38.23 |
| P/OCF Ratio | 9.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.27, with an EV/FCF ratio of 33.58.
| EV / Earnings | n/a |
| EV / Sales | 3.89 |
| EV / EBITDA | 42.27 |
| EV / EBIT | n/a |
| EV / FCF | 33.58 |
Financial Position
The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.85 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 6.10 |
| Debt / FCF | 4.84 |
| Interest Coverage | -44.59 |
Financial Efficiency
Return on equity (ROE) is -4.47% and return on invested capital (ROIC) is -3.01%.
| Return on Equity (ROE) | -4.47% |
| Return on Assets (ROA) | -1.42% |
| Return on Invested Capital (ROIC) | -3.01% |
| Return on Capital Employed (ROCE) | -2.54% |
| Weighted Average Cost of Capital (WACC) | 5.70% |
| Revenue Per Employee | 527,722 |
| Profits Per Employee | -108,915 |
| Employee Count | 595 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, SHA:688089 has paid 3.92 million in taxes.
| Income Tax | 3.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.60% in the last 52 weeks. The beta is 0.38, so SHA:688089's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -68.60% |
| 50-Day Moving Average | 9.10 |
| 200-Day Moving Average | 16.52 |
| Relative Strength Index (RSI) | 56.21 |
| Average Volume (20 Days) | 2,335,482 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688089 had revenue of CNY 313.99 million and -64.80 million in losses. Loss per share was -0.39.
| Revenue | 313.99M |
| Gross Profit | 86.45M |
| Operating Income | -41.81M |
| Pretax Income | -67.03M |
| Net Income | -64.80M |
| EBITDA | 28.46M |
| EBIT | -41.81M |
| Loss Per Share | -0.39 |
Balance Sheet
The company has 351.48 million in cash and 176.07 million in debt, with a net cash position of 175.42 million or 1.07 per share.
| Cash & Cash Equivalents | 351.48M |
| Total Debt | 176.07M |
| Net Cash | 175.42M |
| Net Cash Per Share | 1.07 |
| Equity (Book Value) | 1.54B |
| Book Value Per Share | 9.13 |
| Working Capital | 545.91M |
Cash Flow
In the last 12 months, operating cash flow was 143.85 million and capital expenditures -107.50 million, giving a free cash flow of 36.36 million.
| Operating Cash Flow | 143.85M |
| Capital Expenditures | -107.50M |
| Depreciation & Amortization | 70.27M |
| Net Borrowing | 88.25M |
| Free Cash Flow | 36.36M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 27.53%, with operating and profit margins of -13.31% and -20.64%.
| Gross Margin | 27.53% |
| Operating Margin | -13.31% |
| Pretax Margin | -21.35% |
| Profit Margin | -20.64% |
| EBITDA Margin | 9.06% |
| EBIT Margin | -13.31% |
| FCF Margin | 11.58% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | 0.47% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.44% |
| Shareholder Yield | 2.77% |
| Earnings Yield | -4.66% |
| FCF Yield | 2.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 18, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jul 18, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |